You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 17 No. 2, August 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

"Treatment of Collagen Diseases" and "Treatment of Adrenal Disorders" in Modern Treatment.

By Clarence H. Rupe and Don H. Nelson. Price, $16 per year. Pp 1,500. Hoeber Medical Division, Harper & Row Publishers, New York, Vol 3, No. 6, 1966.

Charles L. Christian, MD, Reviewer

Arch Neurol. 1967;17(2):222-223.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This volume is about equally divided between "collagen diseases" and adrenal disorders. The section on adrenal cortisol insufficiency, Cushing's syndrome, adrenal hyperplasia, hyperaldosteronism, and pheochromocytoma are concise and well written summaries. The contributions on the "collagen diseases," with one, possibly two, exceptions, are not critical. The style of writting is heavy. There are statements that confuse. There are, in the reviewer's opinion, statements that cannot be supported by facts. Some examples are (1) "testicular pain" is common in polyarteritis, (2) the "common pathogenesis" of collagen diseases is autoimmunity, (3) systemic lupus erythematosus (SLE) is described as "frequently involving males,"(4) long-term use of chloroquin (250 mg/day) or hydroxychloroquin (400 mg/ day) "may not be associated with a significant incidence of retinal damage," (5) "severe anaphylactic reactions are more common in patients with SLE than others," (6) in systemic sclerosis "frequent remissions and regressions are seen in the untreated patient," (7) "myopathy . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.